Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Kidney Diseases

arginyl-glycyl-aspartic acid has been researched along with Kidney Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DiBona, GF; Forest, T; Gailit, J; Goligorsky, MS; Miller, F; Noiri, E; Oster, ZH; Romanov, V; Som, P1
Binder, S; Hillemanns, P; Horvat, R; Hovorka, A; Kerjaschki, D; Ojha, PP; Pytela, R; Susani, M1

Reviews

1 review(s) available for arginyl-glycyl-aspartic acid and Kidney Diseases

ArticleYear
Pathophysiology of renal tubular obstruction: therapeutic role of synthetic RGD peptides in acute renal failure.
    Kidney international, 1995, Volume: 48, Issue:5

    Topics: Acute Kidney Injury; Amino Acid Sequence; Animals; Constriction, Pathologic; Humans; Integrins; Kidney Diseases; Kidney Tubules; Oligopeptides; Peptide Fragments

1995

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Kidney Diseases

ArticleYear
A beta 1-integrin receptor for fibronectin in human kidney glomeruli.
    The American journal of pathology, 1989, Volume: 134, Issue:2

    Topics: Adult; Female; Fibronectins; Glomerulonephritis, Membranous; Humans; Immunologic Techniques; Integrins; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Membrane Glycoproteins; Membrane Proteins; Microscopy, Electron; Middle Aged; Oligopeptides; Receptors, Fibronectin; Receptors, Immunologic; Reference Values

1989